CHINA GEWANG BIOTECHNOLOGY, INC. - Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Feb. 29, 2016	Feb. 28, 2015
Income Statement
REVENUE	$ 1,218,098	$ 960,862
Cost of goods sold	(342,608)	(262,358)
Gross profit	875,490	698,504
OPERATING EXPENSES:
Selling and marketing	270,671	153,968
General and administrative	136,961	57,023
TOTAL OPERATING EXPENSES	407,632	210,991
Operating income	467,858	487,513
Other income:
Interest income	4,768	2,440
Other non-operating income	1,488
Total other income	6,256	2,440
Income before provision for income taxes	474,114	489,953
Provision for income taxes	123,416	122,987
Net income before noncontrolling interests	350,698	366,966
Noncontrolling interest	(18,512)	(18,448)
Net income attributable to common stockholders	$ 332,186	$ 348,518
Earnings per common share	$ 0.01	$ 0.01
Weighted average shares outstanding	51,170,330	35,500,000
Comprehensive income (loss):
Net income before noncontrolling interests	$ 350,698	$ 366,966
Foreign currency translation adjustment	(186,413)	(20,177)
Comprehensive (loss) income	145,773	348,789
Comprehensive (loss) income attributable to noncontrolling interests	(9,193)	(17,439)
Net comprehensive (loss) income attributable to common stockholders	$ 136,580	$ 329,350